- Home
- PROK vs PDEX Comparison
PROK vs PDEX Comparison
Compare PROK & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- PDEX
- Stock Information
- Founded
- PROK 2015
- PDEX 1978
- Country
- PROK United States
- PDEX United States
- Employees
- PROK N/A
- PDEX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- PDEX Medical/Dental Instruments
- Sector
- PROK Health Care
- PDEX Health Care
- Exchange
- PROK Nasdaq
- PDEX Nasdaq
- Market Cap
- PROK 126.8M
- PDEX 167.6M
- IPO Year
- PROK N/A
- PDEX N/A
- Fundamental
- Price
- PROK $0.84
- PDEX $55.19
- Analyst Decision
- PROK Buy
- PDEX Strong Buy
- Analyst Count
- PROK 4
- PDEX 1
- Target Price
- PROK $5.00
- PDEX $52.00
- AVG Volume (30 Days)
- PROK 434.6K
- PDEX 41.4K
- Earning Date
- PROK 05-09-2025
- PDEX 05-01-2025
- Dividend Yield
- PROK N/A
- PDEX N/A
- EPS Growth
- PROK N/A
- PDEX 128.87
- EPS
- PROK N/A
- PDEX 1.93
- Revenue
- PROK $76,000.00
- PDEX $61,004,000.00
- Revenue This Year
- PROK N/A
- PDEX $28.63
- Revenue Next Year
- PROK N/A
- PDEX $3.09
- P/E Ratio
- PROK N/A
- PDEX $28.68
- Revenue Growth
- PROK N/A
- PDEX 26.45
- 52 Week Low
- PROK $0.80
- PDEX $16.84
- 52 Week High
- PROK $4.44
- PDEX $59.60
- Technical
- Relative Strength Index (RSI)
- PROK 29.40
- PDEX 73.44
- Support Level
- PROK $0.87
- PDEX $47.00
- Resistance Level
- PROK $1.00
- PDEX $52.00
- Average True Range (ATR)
- PROK 0.10
- PDEX 2.66
- MACD
- PROK 0.01
- PDEX 0.28
- Stochastic Oscillator
- PROK 14.70
- PDEX 86.40
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.